US Patent 7994287 Antibodies which bind human CXCR3
Patent 7994287 was granted and assigned to Millennium Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+493 characters)
Article
Patent abstract
Antibodies and antigen-binding fragments of antibodies that bind human CXCR3 are disclosed. In preferred embodiments, the antibodies are human. Nucleic acids and vectors encoding the antibodies or portions thereof, recombinant cells that contain the nucleic acids, and compositions comprising the antibodies or antigen-binding fragments are also disclosed. The invention also provides therapeutic and diagnostic methods which employ the antibodies and antigen-binding fragments.
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07994287 Antibodies which bind human CXCR3 US Patent 7994287 Antibodies which bind human CXCR3
Infobox
Patent Number
0799428700
Patent Number
799428700
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079942870
Date of Patent
August 9, 2011
0Patent Application Number
122148910
Date Filed
June 23, 2008
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079942870
Date of Patent
August 9, 2011
0Patent Application Number
122148910
Date Filed
June 23, 2008
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07994287 Antibodies which bind human CXCR3
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07994287
Date of patent
August 9, 2011
Patent application number
12214891
Date Filed
June 23, 2008
Patent primary examiner
Find more entities like US Patent 7994287 Antibodies which bind human CXCR3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
